Enhanced and cross-reactive

Humans Multiple Sclerosis / immunology Epstein-Barr Virus Nuclear Antigens / immunology Cross Reactions / immunology Female Male Adult Memory B Cells / immunology Herpesvirus 4, Human / immunology Middle Aged Antibodies, Viral / immunology Epstein-Barr Virus Infections / immunology B-Lymphocytes / immunology Immunologic Memory
EBNA1 Epstein-Barr virus GlialCAM anoctamin-2 memory B cells molecular mimicry multiple sclerosis natalizumab

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 07 11 2023
accepted: 04 04 2024
medline: 11 9 2024
pubmed: 11 9 2024
entrez: 11 9 2024
Statut: epublish

Résumé

Multiple sclerosis (MS) is a prototypical autoimmune disease of the central nervous system (CNS). In addition to CD4

Identifiants

DOI: 10.3389/fimmu.2024.1334720 PMID: 39257578 PMC: PMC11385009
pubmed: 39257578
doi: 10.3389/fimmu.2024.1334720
pmc: PMC11385009
doi:

Substances chimiques

Epstein-Barr Virus Nuclear Antigens 0
EBV-encoded nuclear antigen 1 O5GA75RST7
Antibodies, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1334720

Informations de copyright

Copyright © 2024 Marti, Ruder, Thomas, Bronge, De La Parra Soto, Grönlund, Olsson and Martin.

Déclaration de conflit d'intérêts

Authors ZM and RM were employed by company Cellerys. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Zoe Marti (Z)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Research and Development, Cellerys, Schlieren, Switzerland.
Department of Neuroimmunology and Multiple Sclerosis Research, University Hospital Zurich, Zurich, Switzerland.

Josefine Ruder (J)

Department of Neuroimmunology and Multiple Sclerosis Research, University Hospital Zurich, Zurich, Switzerland.

Olivia G Thomas (OG)

Therapeutic Immune Design Unit, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Mattias Bronge (M)

Therapeutic Immune Design Unit, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.

Lorenzo De La Parra Soto (L)

Therapeutic Immune Design Unit, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.

Hans Grönlund (H)

Therapeutic Immune Design Unit, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Tomas Olsson (T)

Neuroimmunology Unit, Department of Clinical Neurocience, Karolinska Institutet, Stockholm, Sweden.

Roland Martin (R)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Research and Development, Cellerys, Schlieren, Switzerland.
Department of Neuroimmunology and Multiple Sclerosis Research, University Hospital Zurich, Zurich, Switzerland.
Therapeutic Immune Design Unit, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Enhanced and cross-reactive
questionsmedicales.fr › Maladies du système immunitaire › Maladies auto-immunes › Maladies auto-immunes du système nerveux › Maladies démyélinisantes auto-immunes du SNC › Sclérose en plaques › Enhanced and cross-reactive
questionsmedicales.fr › Facteurs biologiques › Antigènes › Antigènes viraux › Antigènes nucléaires du virus d'Epstein-Barr › Enhanced and cross-reactive
questionsmedicales.fr › Phénomènes du système immunitaire › Réaction antigène-anticorps › Réactions croisées › Enhanced and cross-reactive
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Enhanced and cross-reactive
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes B › Sous-populations de lymphocytes B › Cellules B mémoire › Enhanced and cross-reactive
questionsmedicales.fr › Virus › Virus oncogènes › Virus tumoraux à ADN › Gammaherpesvirinae › Lymphocryptovirus › Herpèsvirus humain de type 4 › Enhanced and cross-reactive
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Enhanced and cross-reactive
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Anticorps antiviraux › Enhanced and cross-reactive
questionsmedicales.fr › Infection › Maladies virales › Infections à virus oncogènes › Infections à virus Epstein-Barr › Enhanced and cross-reactive
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes B › Enhanced and cross-reactive
questionsmedicales.fr › Phénomènes du système immunitaire › Immunité › Immunité acquise › Mémoire immunologique › Enhanced and cross-reactive